Avoiding Common Mistakes in Pharma Incentive Compensation Planning Designing compensation plans in pharma is rarely straightforward. What seems fair on paper can sometimes miss the mark in the field, especially when product lifecycles shift or access issues create uneven opportunity. One of the most common challenges we see in pharma incentive compensation planning is overreliance on flat metrics. Quotas that ignore regional complexity or competitive dynamics end up frustrating your best reps and rewarding the wrong behavior. At KMK, we help pharma teams build comp plans that reflect both the data and the context. That often means customizing targets, building smarter tiers, or just asking the right questions before rollout.
Comp doesn’t need to be complicated, but it does need to make sense. Reach us at
[email protected] Website: www.kmkconsultinginc.com
